Key Insights

Highlights

Treatment Research

3 treatments under study, led by Amino Acids

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03013387Phase 2WithdrawnPrimary

Dosimetry Guided PRRT With 90Y-DOTATOC

Showing all 1 trials

Research Network

Common Treatments

  • Amino Acids1
  • Positron Emission Tomography Pet Whole Body Scan1
  • 90ydota3tyroctreotide1

Active Sponsors

  • Sue O'Dorisio1
  • National Cancer Institute (NCI)1
  • National Institutes of Health (NIH)1

Top Investigators

Related Conditions

  • Meningioma1
  • Neuroblastoma1
  • Medulloblastoma1

Activity Timeline